Cargando…
Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis
INTRODUCTION: Regulatory T cells (Treg) play a central role in the immunopathogenesis of psoriasis. Immunoregulatory T cells (Tregs) are involved in important homeostatic mechanism for maintaining tolerance and preventing autoimmunity, and autoimmune diseases. The aim of this study was to examine th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240569/ https://www.ncbi.nlm.nih.gov/pubmed/25568543 http://dx.doi.org/10.5455/medarh.2014.68.236-238 |
_version_ | 1782345734011486208 |
---|---|
author | Karamehic, Jasenko Zecevic, Lamija Resic, Halima Jukic, Majda Jukic, Tomislav Ridjic, Ognjen Panjeta, Mirsad Coric, Jozo |
author_facet | Karamehic, Jasenko Zecevic, Lamija Resic, Halima Jukic, Majda Jukic, Tomislav Ridjic, Ognjen Panjeta, Mirsad Coric, Jozo |
author_sort | Karamehic, Jasenko |
collection | PubMed |
description | INTRODUCTION: Regulatory T cells (Treg) play a central role in the immunopathogenesis of psoriasis. Immunoregulatory T cells (Tregs) are involved in important homeostatic mechanism for maintaining tolerance and preventing autoimmunity, and autoimmune diseases. The aim of this study was to examine the role of Tregs cells in the pathogenesis of psoriasis, and determine the range value for Treg cells (CD4+ CD25+) in the peripheral blood of patients with psoriasis compared to the severity of disease. MATERIAL AND METHODS: The study included 51 patients diagnosed with psoriasis and 25 healthy individuals. Phenotype profile of peripheral blood lymphocytes was determined by flow cytometry, and assessment of severity of disease was determined on the basis of PASI score (e.g. Psoriasis Area and Severity Index). RESULTS: Proportion of CD4+CD25+T cells in the control group was significantly higher than in the patients with psoriasis [6,4% ±(5,4-7,6) vs. 4,1% (3,1 -5,8)–Mann–Whitney U test, p <0.001]. In the present study we did not find a statistically significant correlation between the levels of CD4+CD25+cells, in patients with psoriasis, compared to the severity of disease–PASI. (i.e. Pearson correlation, r = 0.197, p = 0.194). CONCLUSION: The stratification of patients, according to the severity of the clinical course was not possible on the basis of Treg cells’ level. ROC curve analysis of the optimal cutoff (PASI=10) and the CD4+CD25+, which distinguishes between patients and healthy individuals was 5% of CD4+CD25+ of the total number of CD4+ lymphocytes with specificity of 69% and sensitivity of 84%. |
format | Online Article Text |
id | pubmed-4240569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | AVICENA, d.o.o., Sarajevo |
record_format | MEDLINE/PubMed |
spelling | pubmed-42405692015-01-07 Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis Karamehic, Jasenko Zecevic, Lamija Resic, Halima Jukic, Majda Jukic, Tomislav Ridjic, Ognjen Panjeta, Mirsad Coric, Jozo Med Arch Original Article INTRODUCTION: Regulatory T cells (Treg) play a central role in the immunopathogenesis of psoriasis. Immunoregulatory T cells (Tregs) are involved in important homeostatic mechanism for maintaining tolerance and preventing autoimmunity, and autoimmune diseases. The aim of this study was to examine the role of Tregs cells in the pathogenesis of psoriasis, and determine the range value for Treg cells (CD4+ CD25+) in the peripheral blood of patients with psoriasis compared to the severity of disease. MATERIAL AND METHODS: The study included 51 patients diagnosed with psoriasis and 25 healthy individuals. Phenotype profile of peripheral blood lymphocytes was determined by flow cytometry, and assessment of severity of disease was determined on the basis of PASI score (e.g. Psoriasis Area and Severity Index). RESULTS: Proportion of CD4+CD25+T cells in the control group was significantly higher than in the patients with psoriasis [6,4% ±(5,4-7,6) vs. 4,1% (3,1 -5,8)–Mann–Whitney U test, p <0.001]. In the present study we did not find a statistically significant correlation between the levels of CD4+CD25+cells, in patients with psoriasis, compared to the severity of disease–PASI. (i.e. Pearson correlation, r = 0.197, p = 0.194). CONCLUSION: The stratification of patients, according to the severity of the clinical course was not possible on the basis of Treg cells’ level. ROC curve analysis of the optimal cutoff (PASI=10) and the CD4+CD25+, which distinguishes between patients and healthy individuals was 5% of CD4+CD25+ of the total number of CD4+ lymphocytes with specificity of 69% and sensitivity of 84%. AVICENA, d.o.o., Sarajevo 2014-08 2014-07-31 /pmc/articles/PMC4240569/ /pubmed/25568543 http://dx.doi.org/10.5455/medarh.2014.68.236-238 Text en Copyright: © AVICENA http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Karamehic, Jasenko Zecevic, Lamija Resic, Halima Jukic, Majda Jukic, Tomislav Ridjic, Ognjen Panjeta, Mirsad Coric, Jozo Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis |
title | Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis |
title_full | Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis |
title_fullStr | Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis |
title_full_unstemmed | Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis |
title_short | Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis |
title_sort | immunophenotype lymphocyte of peripheral blood in patients with psoriasis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240569/ https://www.ncbi.nlm.nih.gov/pubmed/25568543 http://dx.doi.org/10.5455/medarh.2014.68.236-238 |
work_keys_str_mv | AT karamehicjasenko immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis AT zeceviclamija immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis AT resichalima immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis AT jukicmajda immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis AT jukictomislav immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis AT ridjicognjen immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis AT panjetamirsad immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis AT coricjozo immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis |